You can be on Entrepreneur’s cover!

Pfizer Says COVID-19 Vaccine Efficacy Weakens Over Time Pfizer said that booster doses should be given to all people aged 16 and older six months after they received their second dose of the mRNA vaccine.

By The Epoch Times

entrepreneur daily

Opinions expressed by Entrepreneur contributors are their own.

Pfizer said that data from Israel and the United States suggests that its COVID-19 vaccine efficacy drops over time and claimed that booster doses are effective at dealing with new virus variants.

Federal health officials two weeks ago announced a target date of Sept. 20 to try and roll out booster shots for the general public, although a recent study from several top scientists at the World Health Organization and Food and Drug Administration (FDA) found that the general population doesn't need a booster dose.

"Real-world data from Israel and the United States suggest that rates of breakthrough infections are rising faster in individuals who were vaccinated earlier in the vaccination campaigns compared to those who have been vaccinated more recently," Pfizer said during its presentation this week, which was posted on the FDA website.

And the evidence from the studies indicates that the "observed decrease of vaccine effectiveness against COVID-19 infections is primarily due to waning of vaccine immune responses over time rather than a result of the Delta variant escaping vaccine protection," said Pfizer.

Based on its data, Pfizer said that booster doses should be given to all people aged 16 and older six months after they received their second dose of the mRNA vaccine.

The pharmaceutical giant, which partnered with BioNTech for its vaccine, cited a study from healthcare giant Kaiser Permanente that suggested protection against COVID-19 infection dropped from 88 percent in the first month of getting the second dose to 47 percent after five months.

The company is attempting to make an argument ahead of a crucial FDA meeting scheduled for Friday, where a panel is slated to debate and vote on whether to recommend booster shots, or a third dose.

But in a study published by The Lancet on Monday, two senior FDA vaccine reviewers who are expected to leave the agency soon and more than a dozen top researchers argued that booster shots aren't needed for the general population. They argued that potential side-effects from the extra doses could outweigh the benefits, arguing that such a phenomenon would actually increase vaccine hesitance.

"Current evidence does not … appear to show a need for boosting in the general population, in which efficacy against severe disease remains high," the study published in the Lancet said. "Even if boosting were eventually shown to decrease the medium-term risk of serious disease, current vaccine supplies could save more lives if used in previously unvaccinated populations," the authors wrote.

Meanwhile, WHO Director-General Tedros Adhanom Ghebreyesus earlier this month issued a sharply worded statement calling on wealthier nations including the United States to place a moratorium on booster shots until the end of this year. Because companies are ramping up production of the extra vaccine doses, it deprives poorer nations of initial vaccines, he argued at a news conference.

"I will not stay silent when companies and countries that control the global supply of vaccines think the world's poor should be satisfied with leftovers," he told a news conference on Sept. 8. "Because manufacturers have prioritized or been legally obliged to fulfill bilateral deals with rich countries willing to pay top dollar, low-income countries have been deprived of the tools to protect their people."

COVID-19 is the disease caused by the CCP (Chinese Communist Party) virus.

By Jack Phillips

Jack Phillips is a reporter at The Epoch Times based in New York.

The Epoch Times, founded in 2000, is headquartered in Manhattan, New York, with a mission to provide independent and accurate information free of political bias or corporate influence. The organization was established in response to censorship within China and a lack of global awareness regarding the Chinese regime's repression of the spiritual practice Falun Gong.

The Epoch Times is a widely read newspaper that is distributed in 33 countries and is available in 21 languages. The publication has been critical in providing balanced and detailed reporting on major global events such as the 2003 SARS pandemic and the 2008 financial crisis. Notably, the organization has played a key role in exposing corruption inside China.

Aside from its human rights coverage, The Epoch Times has made significant contributions in a variety of fields. It has received praise for its in-depth analysis and expert perspectives on business, the economy and U.S. politics. The newspaper has also received praise for its broad coverage of these topics.

A series of editorials titled "Nine Commentaries on the Communist Party" appeared in The Epoch Times in 2004. It asserts that freedom and prosperity in China can only be achieved by eliminating the Communist Party, which violated China's cultural and spiritual values. In addition, the organization led the Tuidang movement, which resulted in over 400 million Chinese citizens quitting the Communist Party. In spite of this, 90% of websites referring to the "Nine Commentaries" were blocked by the Chinese regime.

The Epoch Times has been at the forefront of investigating high-level corruption cases within the Chinese regime, with its reporters taking significant risks to uncover these stories. The organization has received several awards for its investigative journalism.

The organization has received several awards for its investigative journalism. For more, visit www.theepochtimes.com.

Want to be an Entrepreneur Leadership Network contributor? Apply now to join.

Editor's Pick

Business News

This Highly-Debated Piece of Cinematic History Just Sold For Over $700,000 at Auction

The wood panel from "Titanic" is often mistaken as a door. Either way, he couldn't have fit. (Sorry.)

Business Ideas

63 Small Business Ideas to Start in 2024

We put together a list of the best, most profitable small business ideas for entrepreneurs to pursue in 2024.

Business News

From Tom Brady to Kevin O'Leary – See Who Lost Big in the Wake of the FTX Crypto Collapse

The crash exposed an $8 billion hole in FTX's accounts, leaving investors and customers scrambling to recoup their funds.

Money & Finance

5 Simple Wealth-Building Tips For This Generation's Forward-Thinkers

Explore practical finance tips for young professionals striving to overcome economic challenges.